Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7749 USD | +1.96% | +3.32% | +5.43% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.43% | 20.53M | |
+11.65% | 107B | |
-5.17% | 28.56B | |
+11.79% | 22.18B | |
-13.85% | 18.16B | |
-7.70% | 17.05B | |
+14.88% | 15.89B | |
-10.87% | 11.09B | |
-2.93% | 10.39B | |
-2.81% | 9.65B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Alpine 4 Holdings Subsidiary Developing 'Bully Class' of Infiltration, Anti-Airspace Drones